09:04 Fri 02 Oct 2020
Dechra Pharm PLC - Director/PDMR Shareholding
Dechra® Pharmaceuticals PLC
(Dechra or the Company)
Notification and public disclosure of transactions by
persons discharging managerial responsibilities (PDMRs)
Dechra Pharmaceuticals PLC announces that on
| Date of Grant | Scheme | Number of options exercised | Option Price | Number of shares sold | Sale Price |
| | Approved | 923 | | Nil | N/A |
| | Approved | 526 | | Nil | N/A |
| | Unapproved | 2,474 | | 2,474 | |
The Notification of Dealing Forms set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.
Notification of Dealing Forms
| 1. | Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA") | ||
| a) | Name |
| |
| 2. | Reason for the notification | ||
| a) | Position/status | Director/PDMR
| |
| b) | Initial notification/ amendment | Initial Notification | |
| 3. | Details of the Issuer | ||
| a) | Name | Dechra Pharmaceuticals PLC | |
| b) | LEI code | 213800J4UVB5OWG8VX82
| |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument
Identification code | Ordinary Shares of
ISIN: GB0009633180 | |
| b) | Nature of the transaction | Exercise of options under the Company's Approved Option Scheme
| |
| c) | Price(s) and volumes(s) | Price(s) | Volume(s) 923 526 |
| d) | Aggregated information - Aggregate volume - Price - Total |
1,449 | |
| e) | Date of the transaction | 2020.10.01 | |
| f) | Place of the transaction | Outside a trading venue | |
| 1. | Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA") | ||
| a) | Name |
| |
| 2. | Reason for the notification | ||
| a) | Position/status | Director/PDMR
| |
| b) | Initial notification/ amendment | Initial Notification | |
| 3. | Details of the Issuer | ||
| a) | Name | Dechra Pharmaceuticals PLC | |
| b) | LEI code | 213800J4UVB5OWG8VX82
| |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument
Identification code | Ordinary Shares of
ISIN: GB0009633180 | |
| b) | Nature of the transaction | Exercise of options under the Company's Unapproved Option Scheme
| |
| c) | Price(s) and volumes(s) | Price(s) | Volume(s) 2,474 |
| d) | Aggregated information - Aggregate volume - Price - Total |
2,474
| |
| e) | Date of the transaction | 2020.10.01 | |
| f) | Place of the transaction | Outside a trading venue | |
| 1. | Details of the Person Discharging Managerial Responsibility ("PDMR")/person closely associated with them ("PCA") | ||
| a) | Name |
| |
| 2. | Reason for the notification | ||
| a) | Position/status | Director/PDMR
| |
| b) | Initial notification/ amendment | Initial Notification | |
| 3. | Details of the Issuer | ||
| a) | Name | Dechra Pharmaceuticals PLC | |
| b) | LEI code | 213800J4UVB5OWG8VX82
| |
| 4. | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||
| a) | Description of the financial instrument
Identification code | Ordinary Shares of
ISIN: GB0009633180 | |
| b) | Nature of the transaction | Sale of shares obtained under the Company's Unapproved Share Option Scheme
| |
| c) | Price(s) and volumes(s) | Price(s) £32.23 | Volume(s) 2,474 |
| d) | Aggregated information - Aggregate volume - Price - Total |
2,474
£32.23 | |
| e) | Date of the transaction | 2020.10.01 | |
| f) | Place of the transaction | London Stock Exchange | |
For further information, please contact:
Telephone number: 01606 814730
About Dechra
Dechra is a global specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacture, and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information please visit: www.dechra.com
Trademarks
Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
NO INVESTMENT ADVICE
The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...
FOR OUR FULL DISCLAIMER CLICK HERE
